Role of serum lipoprotein (a) in type 2 diabetes mellitus and its association with glycemic control

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2018, Vol 5, Issue 3

Abstract

Diabetes mellitus DM is an established risk factor for cardiovascular disease At present global risk assessment lipid profile is only the blood test routinely recommended most commonly Increased lipoprotein a Lpa contributing factor to accelerated development of macrovascular complications in DM However Lpa and hsCRP evaluation may have the potential to improve cardiovascular risk prediction when used in addition to traditional lipid profile Hence the study was undertaken to estimate the serum lipoprotein a lipid profile lipid ratios and hsCRP in diabetic patients and their association with glycemic control Within the diabetic patients we examined Lpa levels among controlled and uncontrolled diabetic individualsMaterials and Methods An observational study comprises of 150 participants 75 were type 2 diabetic patients and 75 were healthy controls Diabetic patients were further sub classified into good and poor glycemic control group depending on their HbA1c levels 75 as cutoff value Fasting venous blood sample was collected and used for analysis of fasting glucose lipoprotein a lipid profile high sensitive C reactive protein hsCRP and glycosylated hemoglobin HbA1cResults A significant increase p Conclusion The study helps in identification of at risk individuals for CAD beyond the routinely done lipid profile especially in insufficient resource situations In our study we have higher levels of Lpa hsCRP and other atherogenic risk factors cluster more in diabetic patients compared to healthy controls FBS TG hsCRP and TGHDL are positively correlated with HbA1c Thus Lpa and hsCRP evaluation may have the potential to improve cardiovascular risk prediction when used in addition to traditional lipid profile in diabetic patients Poor glycemic control subjects have significantly higher hsCRP and TGs compared to good glycemic controls There is no effect of glycemic control on Lpa levels hence Lpa is independent risk factor for CAD in diabetic patientsKeywords Lipoprotein a Glycemic contol Diabetes mellitus

Authors and Affiliations

Kavitha MM, JG Ambekar, Nilima Dongre, Kashinakunti SV

Keywords

Related Articles

Analysis of serum ferritin levels in non-diabetic, prediabetic and diabetic individuals

Introduction: Type 2 diabetes mellitus (T2DM) is characterized by impaired insulin secretion, insulin resistance or both. In the initial asymptomatic phase there is hyperinsulinemia, as insulin resistance progress and be...

Association between type 2 diabetes mellitus and hypovitaminosis D

Introduction: Vitamin D is an important component in regulating the biological functions of the body in various ways. Many studies repeatedly explained the role of vitamin D in the pathogenesis and treatment of various d...

A study of pre-analytical variables and quality improvement in testing process of clinical laboratory

Introduction: Laboratory tests are important to diagnose the diseases, to monitor the progress and to see the response to the treatment of patients. Pre-analytical variables include specimen collection, timing, transport...

Normative data of the urinary bone resorption biomarkers for osteoporosis DPD, CTx and NTx among females in Manipur and its correlation with bone mineral density measured by DEXA scan

Introduction Osteoporosis has become a major public health problem affecting more than 100 million people worldwide Standard diagnosis depends on measuring bone mineral density BMD using a dual energy Xray absorptiometry...

Fractional excretion of sodium (FENa): A paraphernalia in incipient nephropathy versus overt nephropathy in Type I Diabetes Mellitus

An estimated 40% of patients diagnosed with Type I diabetes and 5 - 15% of patients with Type II diabetes eventually develop ESRD and diabetes has become the leading cause (44%) of end-stage renal disease in India. There...

Download PDF file
  • EP ID EP475198
  • DOI 10.18231/2394-6377.2018.0092
  • Views 38
  • Downloads 0

How To Cite

Kavitha MM, JG Ambekar, Nilima Dongre, Kashinakunti SV (2018). Role of serum lipoprotein (a) in type 2 diabetes mellitus and its association with glycemic control. International Journal of Clinical Biochemistry and Research, 5(3), 435-440. https://europub.co.uk/articles/-A-475198